| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |